Does earlier headache response equate to earlier return to functioning in patients suffering from migraine?

Cephalalgia

Volumn 26, Issue 4, 2006, Pages 428-435

  Pradel, F G ^a   Subedi, P ^a   Varghese, A A ^a   Mullins, C D ^a   Weis, K A ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b PFIZER INC   (United States)

Author keywords

Functioning; Headache; Migraine; Satisfaction

Indexed keywords

TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; FUNCTIONAL ASSESSMENT; HEADACHE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN ASSESSMENT; PAIN THRESHOLD; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT INFORMATION; PATIENT PARTICIPATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DOUBLE-BLIND METHOD; FEMALE; HEADACHE; HUMANS; INCIDENCE; MALE; MARYLAND; MIDDLE AGED; MIGRAINE DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PYRROLIDINES; RECOVERY OF FUNCTION; SEROTONIN AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME; TRYPTAMINES;

EID: 33645119111     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2005.01043.x     Document Type: Article

References (28)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 8 Suppl. 7 1 96.
2. Cady RK. Focus on primary care female population with migraine. Obstet Gynecol Surv 1999 54 12 Suppl. Focus S7 13.
3. Mental health: new understanding, new hope. The World Health Report. Geneva World Health Organization 2001.
4. Stewart WF Lipton RB Celentano DD Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 1992 267 64 9.
5. Lipton RB Stewart WF Diamond S Diamond ML Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001 41 646 57.
6. Brandes JL. Global trends in migraine care: results from the MAZE survey. CNS Drugs 2002 16 Suppl. 1 13 8.
7. Silberstein SD. Migraine. Lancet 2004 363 9406 381 91.
8. Lipton RB Hamelsky SW Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002 42 Suppl. 1 3 9.
9. Lipton RB Bigal ME Kolodner K Stewart WF Liberman JN Steiner TJ. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia 2003 23 429 40.
10. Tulen JH Stronks DL Bussmann JB Pepplinkhuizen L Passchier J. Towards an objective quantitative assessment of daily functioning in migraine: a feasibility study. Pain 2000 86 139 49.
11. Ryan RE Jr.. Patient treatment preferences and the 5-HT1B/1D agonists. Arch Intern Med 2001 161 2545 53.
12. Caro G Caro JJ O'Brien JA Anton S Jackson J. Migraine therapy: development and testing of a patient preference questionnaire. Headache 1998 38 602 7.
13. Stronks DL Tulen JH Bussmann JB Mulder LJ Passchier J. Interictal daily functioning in migraine. Cephalalgia 2004 24 271 9.
14. Stang P Cady R Batenhorst A Hoffman L. Workplace productivity. A review of the impact of migraine and its treatment. Pharmacoeconomics 2001 19 231 44.
15. Ferrari MD. The economic burden of migraine to society. Pharmacoeconomics 1998 13 667 76.
16. Gerth WC Carides GW Dasbach EJ Visser WH Santanello NC. The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics 2001 19 197 206.
17. Gerth WC Sarma S Hu XH Silberstein SD. Productivity cost benefit to employers of treating migraine with rizatriptan: a specific worksite analysis and model. J Occup Environ Med 2004 46 48 54.
18. Schwartz BS Stewart WF Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med 1997 39 320 7.
19. Hu XH Markson LE Lipton RB Stewart WF Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999 159 813 8.
20. Fishman P Black L. Indirect costs of migraine in a managed care population. Cephalalgia 1999 19 50 7 ; discussion 1.
21. MacGregor EA Brandes J Eikermann A Giammarco R. Impact of migraine on patients and their families: the Migraine and Zolmitriptan Evaluation (MAZE) survey - Phase III. Curr Med Res Opin 2004 20 1143 50.
22. Fagan MA. Exploring the relationship between maternal migraine and child functioning. Headache 2003 43 1042 8.
23. Kryst S Scherl E. A population-based survey of the social and personal impact of headache. Headache 1994 34 344 50.
24. Terwindt GM Ferrari MD Tijhuis M Groenen SM Picavet HS Launer LJ. The impact of migraine on quality of life in the general population: the GEM study. Neurology 2000 55 624 9.
25. Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache 1995 35 387 96.
26. Lipton R Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999 39 Suppl. 2 S20 S26.
27. Davies GM Santanello N Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000 20 554 60.
28. Taylor TR. Understanding the choices that patients make. J Am Board Fam Pract 2000 13 124 33.